To determine whether the TCTP inhibitor sertraline could target prostate cancer stem cells.To investigate the effects of sertraline on in vitro tumorigenesis and metastasis properties while also delineating its anticancer mechanism. This evidence concerns the gene TPT1 and Familial prostate cancer.